Haemonetics Corp
Change company Symbol lookup
Select an option...
HAE Haemonetics Corp
GTN Gray Television Inc
GS Goldman Sachs Group Inc
BSYI Biosyntech Inc
NHF NexPoint Strategic Opportunities Fund
LOTE Lot78 Inc
EROS Eros International PLC
NH NantHealth Inc
TEVA Teva Pharmaceutical Industries Ltd
VMW VMware Inc

Health Care : Health Care Equipment & Supplies | Mid Cap GrowthCompany profile

Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.

Closing Price
Day's Change
1.83 (2.12%)
B/A Size
Day's High
Day's Low
(Below Average)

10-day average volume:

Goldman stock jumps after extending beat streak, despite 'challenging' market-making environment

8:03 am ET January 16, 2019 (MarketWatch)

Shares of Goldman Sachs Group Inc. (GS) shot up 2.8% in premarket trade Wednesday, after the blue-chip broker stretched its earnings and revenue beat streak to seven quarters, despite a "challenging" market-making environment. Total revenue fell to $8.08 billion from $8.12 billion, but was above the FactSet consensus of $7.50 billion. The revenue beat comes after major-bank peers Citigroup Inc. (C), J.P. Morgan Chase & Co. (JPM) and Wells Fargo & Co. (WFC) missed expectations, while Bank of America Corp. (BAC) topped. For Goldman, the investing and lending business had the biggest beat, with revenue falling 2.1% to $1.91 billion compared with the FactSet consensus of $1.35 billion. Investment banking revenue declined 4.5% to $2.04 billion, above the FactSet consensus of $1.88 billion, and investment management revenue grew 2.5% to $1.70 billion to top expectations of $1.69 billion. That offset a miss in the institutional client services business, where revenue rose 2.3% to $2.43 billion but was below the FactSet consensus of $2.58 billion. Goldman's stock has tumbled 19% over the past three months through Tuesday, while the SPDR Financial Select Sector ETF (XLF) has declined 7.0% and the Dow Jones Industrial Average fell 6.7%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

January 16, 2019 08:03 ET (13:03 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.